Aprea Therapeutics, Inc. (APRE)
↓ Download CSVKey ratios (FY2025)
-101.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$13.23M | -$14.32M | -$15.47M | -$113.39M | -$37.45M | — | — | — | — | — |
| Net Income | -$12.60M | -$12.96M | -$14.29M | -$112.66M | -$37.13M | -$53.48M | -$28.06M | -$15.53M | -$15.19M | — |
| EPS (Diluted) | $-1.93 | $-2.35 | $-3.95 | $-67.99 | $-34.88 | $-50.61 | $-4.67 | — | — | — |
| Total Assets | $15.93M | $23.98M | $22.65M | $30.16M | $56.82M | $92.81M | $133.61M | $66.02M | — | — |
| Total Liabilities | — | — | — | $3.20M | $7.32M | $15.41M | $9.36M | $4.87M | — | — |
| Shareholders' Equity | $12.44M | $19.31M | $16.95M | $25.64M | $49.51M | $77.40M | $124.24M | -$51.44M | -$35.77M | -$21.47M |
| Cash & Equivalents | $14.60M | $22.85M | $21.61M | $28.79M | $53.08M | $89.02M | $130.09M | $65.68M | — | — |
| Operating Cash Flow | -$12.89M | -$13.56M | -$12.18M | -$25.01M | -$37.69M | -$41.80M | -$26.71M | -$15.25M | -$14.00M | — |
| Capital Expenditures | — | $15.5K | $93.1K | — | — | $25.7K | $30.9K | $3.7K | — | — |
| Shares Outstanding | 8.19M | 5.48M | 3.74M | 2.66M | 1.09M | 21.19M | 21.02M | 1.16M | — | — |